Dual Antiplatelet Therapy Beyond 1 Year Postinfarction: The Time Has Come and We're Beginning to Know Who Will Benefit

Rev Esp Cardiol (Engl Ed). 2016 May;69(5):471-3. doi: 10.1016/j.rec.2016.01.020. Epub 2016 Mar 31.
[Article in English, Spanish]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Acute Coronary Syndrome / drug therapy*
  • Adenosine / administration & dosage
  • Adenosine / analogs & derivatives
  • Aspirin / administration & dosage
  • Clopidogrel
  • Drug Therapy, Combination
  • Humans
  • Myocardial Infarction / drug therapy*
  • Patient Selection
  • Platelet Aggregation Inhibitors / administration & dosage*
  • Prasugrel Hydrochloride / administration & dosage
  • Secondary Prevention
  • Ticagrelor
  • Ticlopidine / administration & dosage
  • Ticlopidine / analogs & derivatives
  • Time Factors

Substances

  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Prasugrel Hydrochloride
  • Ticagrelor
  • Adenosine
  • Ticlopidine
  • Aspirin